Breathe Well Live Well
|
Array says asthma drug improves lung function in study, seeks partner for …
MedCity News (Reuters) – Array Biopharma Inc said one of its drugs met the main goal of improving lung function in a mid-stage study among patients with mild to moderate persistent allergic asthma. Array shares rose as much as 19 percent to $6.64 — their highest … |
View full post on asthma – Google News
|
Array Seeks Asthma Drug Partner Following Mid-Stage Study Results
TheStreet.com BOULDER, Col. (TheStreet) — An experimental pill from Array BioPharma (ARRY) improved lung function in patients who suffer from asthma brought on by allergies, according to results from a small mid-stage study announced Tuesday. Array shares rose 15 … |
View full post on asthma – Google News
|
GSK, FivePrime partner to discover new asthma and COPD treatments
MedCity News Under the new partnership, the companies aim to find new ways to treat asthma and chronic obstructive pulmonary disorder, or COPD. Over the next four years, privately held FivePrime stands to gain up to $30 million from the new deal in the form of … Five Prime strikes deal with GSK for asthma drug Five Prime, GSK sign strategic drug discovery alliance Five Prime Therapeutics Announces Second Strategic Alliance With GlaxoSmithKline |
View full post on asthma – Google News
|
ACAAI, Teva Respiratory partner to bring free asthma screenings nationwide
News-Medical.net The American College of Allergy, Asthma and Immunology (ACAAI) recognizes Teva Respiratory for its continued leadership and support of important educational issues related to respiratory health, particularly under diagnosed and poorly managed asthma … |
View full post on asthma – Google News
|
iSonea gains partner to develop new mobile asthma monitoring system
Proactive Investors UK iSonea (ASX: ISN, OTCQX: ISOAY) has entered a partnership with telecommunications company Qualcomm Life, a wholly owned subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), to design and market a home and mobile asthma monitoring platform. |
View full post on asthma – Google News
|
iSonea gains partner to develop new mobile asthma monitoring system
Proactive Investors Australia They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is a step closer to achieving a core objective of its commercialisation plan of developing over-the-counter asthma monitoring devices with mobile … |
View full post on asthma – Google News
|
IBM and Georgia Institute of Technology Partner on "One Million Healthy …
PR Newswire (press release) The project, which includes partnerships with Emory University, Children's Healthcare of Atlanta, Georgia Cancer Coalition and the Georgia Department of Community Health, will focus initially on children suffering from diabetes, asthma and autism. … |
View full post on asthma – Google News
|
Ventura bags major US partner for COPD/asthma combo copy
Pharma Times … division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair. … Vectura Signs Up US Partner For VR315 Lung Drug Vectura signs US license agreement for VR315 product Vectura gets new US partner for copy of lung drug |
View full post on asthma – Google News
|
Vectura Signs Up US Partner For VR315 Lung Drug
NASDAQ LN) said Wednesday it has signed a US licensing deal for its generic asthma medicine VR315 with an unnamed "leading international pharmaceutical company." VR315, a drug that industry observers say is a copycat version of GlaxoSmithKline PLC's (GSK. … Vectura signs US license agreement for VR315 product Vectura gets new US partner for copy of lung drug US deal for Vectura; takeover bid for AMAG |
View full post on asthma – Google News